Kubasch, Anne Sophie
Schulze, Freya
Giagounidis, Aristoteles
Götze, Katharina S.
Krönke, Jan http://orcid.org/0000-0002-4649-0506
Sockel, Katja
Middeke, Jan Moritz
Chermat, Fatiha
Gloaguen, Silke
Puttrich, Martin
Weigt, Carmen
William, Doreen
Fenaux, Pierre
Schlenk, Richard F.
Thiede, Christian
Stasik, Sebastian
Mies, Anna
Adès, Lionel
Oelschlägel, Uta
Platzbecker, Uwe
Funding for this research was provided by:
Janssen Pharmaceuticals
Article History
Received: 22 July 2019
Revised: 17 October 2019
Accepted: 3 November 2019
First Online: 3 December 2019
Compliance with ethical standards
:
: Uwe Platzbecker, Research funding: Janssen Pharmaceuticals. Consultancy and Honoraria: Novartis, Abbvie, Celgene. AG, Research funding: Janssen Pharmaceuticals. KG: Research funding: Janssen Pharmaceuticals. Advisory committee: Abbvie. MP: Research funding: Janssen Pharmaceuticals. CW: Research funding: Janssen Pharmaceuticals. PF: Research funding: Janssen Pharmaceuticals. Richard Schlenk, Honoraria and Research Funding: Teva Pharmaceutical Industries. CT, Employment and Equity Ownership: AgenDix GmbH, Consultancy, Honoraria, Research Funding and Speakers Bureau: Novartis, Honararia: Daiichi Sankyo. LA: Research funding: Janssen Pharmaceuticals. Consultancy and Honoraria: Celgene, Novartis, Takeda Jazz, Abbvie. UO: Research funding: Janssen Pharmaceuticals. ASK, FS, JK, KS, JMM, FC, SG, DW, SS, and AM declare no relevant conflicts of interests.